1. Home
  2. TECX vs DVS Comparison

TECX vs DVS Comparison

Compare TECX & DVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc. Common Stock

TECX

Tectonic Therapeutic Inc. Common Stock

HOLD

Current Price

$20.98

Market Cap

359.0M

Sector

N/A

ML Signal

HOLD

DVS

Dolly Varden Silver Corporation Common Shares

HOLD

Current Price

$4.58

Market Cap

409.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
DVS
Founded
2019
2011
Country
United States
Canada
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
359.0M
409.7M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
TECX
DVS
Price
$20.98
$4.58
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$81.20
N/A
AVG Volume (30 Days)
407.9K
803.2K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.70
$2.30
52 Week High
$61.07
$5.38

Technical Indicators

Market Signals
Indicator
TECX
DVS
Relative Strength Index (RSI) 59.16 60.68
Support Level $18.60 $4.39
Resistance Level $22.00 $4.78
Average True Range (ATR) 1.72 0.25
MACD 0.09 0.11
Stochastic Oscillator 78.88 81.36

Price Performance

Historical Comparison
TECX
DVS

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About DVS Dolly Varden Silver Corporation Common Shares

Dolly Varden Silver Corp is a mineral exploration company. The company's primary business is the acquisition, exploration, evaluation, and development of exploration and evaluation assets. It is focused on exploration advancing the Kitsault Valley Project, which includes the Dolly Varden property and the Homestake Ridge property located in the Golden Triangle of British Columbia, Canada.

Share on Social Networks: